Tags

Type your tag names separated by a space and hit enter

Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase.
Metabolism. 2009 Oct; 58(10):1408-14.M

Abstract

Metformin is known to increase lipoprotein lipase (LPL) mass level in serum. Lipoprotein lipase is produced by adipose tissue and skeletal muscles. This study aimed to examine the effect of metformin on LPL production in adipocytes and skeletal muscle cells and to investigate the mechanism by which metformin enhances LPL production. 3T3-L1 preadipocytes and L6 skeletal muscle cells were incubated with metformin or 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Lipoprotein lipase activity, LPL protein expression, and LPL messenger RNA (mRNA) expression were measured. Metformin increased LPL activity only in skeletal muscle cells. To clarify the mechanism of this phenomenon, AICAR, which is well known as an activator of adenosine monophosphate-activated protein kinase (AMPK), was used. Metformin and AICAR enhanced phosphorylated AMPK in skeletal muscle cells by Western blot analysis. Like metformin, AICAR increased LPL activity only in skeletal muscle cells. Both metformin and AICAR also enhanced LPL protein and LPL mRNA expressions in skeletal muscle cells but not in adipocytes. Phosphorylated AMPK protein expression was decreased when AMPK signaling was interfered by AMPKalpha small interfering RNA. Lipoprotein lipase activity and LPL expression, which were enhanced by 1 mumol/L metformin, were reduced by AMPKalpha small interfering RNA. These results suggest that metformin increases LPL activity, LPL protein expression, and LPL mRNA expression through activation of AMPK in skeletal muscle cells but not in adipocytes.

Authors+Show Affiliations

Center of Diabetes, Endocrine and Metabolism, Sakura Hospital, Medical Center, Toho University, 564-1 Shimoshizu, Sakura-City, Chiba 285-0841, Japan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19570550

Citation

Ohira, Masahiro, et al. "Metformin Promotes Induction of Lipoprotein Lipase in Skeletal Muscle Through Activation of Adenosine Monophosphate-activated Protein Kinase." Metabolism: Clinical and Experimental, vol. 58, no. 10, 2009, pp. 1408-14.
Ohira M, Miyashita Y, Murano T, et al. Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase. Metabolism. 2009;58(10):1408-14.
Ohira, M., Miyashita, Y., Murano, T., Watanabe, F., & Shirai, K. (2009). Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase. Metabolism: Clinical and Experimental, 58(10), 1408-14. https://doi.org/10.1016/j.metabol.2009.04.024
Ohira M, et al. Metformin Promotes Induction of Lipoprotein Lipase in Skeletal Muscle Through Activation of Adenosine Monophosphate-activated Protein Kinase. Metabolism. 2009;58(10):1408-14. PubMed PMID: 19570550.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase. AU - Ohira,Masahiro, AU - Miyashita,Yoh, AU - Murano,Takeyoshi, AU - Watanabe,Fusako, AU - Shirai,Kohji, Y1 - 2009/07/01/ PY - 2008/02/13/received PY - 2009/04/10/accepted PY - 2009/7/3/entrez PY - 2009/7/3/pubmed PY - 2009/10/10/medline SP - 1408 EP - 14 JF - Metabolism: clinical and experimental JO - Metabolism VL - 58 IS - 10 N2 - Metformin is known to increase lipoprotein lipase (LPL) mass level in serum. Lipoprotein lipase is produced by adipose tissue and skeletal muscles. This study aimed to examine the effect of metformin on LPL production in adipocytes and skeletal muscle cells and to investigate the mechanism by which metformin enhances LPL production. 3T3-L1 preadipocytes and L6 skeletal muscle cells were incubated with metformin or 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Lipoprotein lipase activity, LPL protein expression, and LPL messenger RNA (mRNA) expression were measured. Metformin increased LPL activity only in skeletal muscle cells. To clarify the mechanism of this phenomenon, AICAR, which is well known as an activator of adenosine monophosphate-activated protein kinase (AMPK), was used. Metformin and AICAR enhanced phosphorylated AMPK in skeletal muscle cells by Western blot analysis. Like metformin, AICAR increased LPL activity only in skeletal muscle cells. Both metformin and AICAR also enhanced LPL protein and LPL mRNA expressions in skeletal muscle cells but not in adipocytes. Phosphorylated AMPK protein expression was decreased when AMPK signaling was interfered by AMPKalpha small interfering RNA. Lipoprotein lipase activity and LPL expression, which were enhanced by 1 mumol/L metformin, were reduced by AMPKalpha small interfering RNA. These results suggest that metformin increases LPL activity, LPL protein expression, and LPL mRNA expression through activation of AMPK in skeletal muscle cells but not in adipocytes. SN - 1532-8600 UR - https://www.unboundmedicine.com/medline/citation/19570550/Metformin_promotes_induction_of_lipoprotein_lipase_in_skeletal_muscle_through_activation_of_adenosine_monophosphate_activated_protein_kinase_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0026-0495(09)00179-6 DB - PRIME DP - Unbound Medicine ER -